Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors

Overview of attention for article published in OncoImmunology, February 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 2,178)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 46 news outlets

twitter: 1 X user

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 20 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 4,397 followers.

This research has been discussed in over 40 news outlets! 🗞️ It looks into T cells, their receptors and how they can be modified to increase their antitumor potency 🦠 📖 Read it here: https://t.co/iZY5NBAiDw #Oncology #Immunology #MedTwitter https://t.

13 Jun 2023

Reply Repost Favourite

This research has been discussed in over 40 news outlets! 🗞️ It looks into T cells, their receptors and how they can be modified to increase their antitumor potency 🦠 📖 Read it here: https://t.co/HoHiZYUqXV #Oncology #Immunology #MedTwitter https://t.

30 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.